While most reports suggest that Epac promotes cancer cells proliferation in prostate cancer, one study showed that Epac inhibits cell proliferation in PC-3 and DU 145 prostate cancer cell lines by inhibiting MAPK pathway and therefore decreasing DNA synthesis [60]. This evidence concerns the gene RAPGEF3 and cancer.